We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Macy's (M) Q4 Earnings Beat, Strategic Initiatives on Track
Read MoreHide Full Article
Macy’s, Inc. (M - Free Report) delivered the seventh straight quarter of positive earnings surprise, when it reported fourth-quarter fiscal 2018 results. Management hinted that while the company registered positive comparable sales, results failed to live up to expectations. Nonetheless, the company witnessed double-digit growth in the digital business.
The company highlighted that going forward it will embark on Backstage, Vendor Direct, Store Pickup, Loyalty Program, Growth50 stores, ‘mobile first’ strategy and Destination Businesses to drive growth. The company plans to double the number of Market @ Macy’s, a store-within-a-store retail concept. This Zacks Rank #3 (Hold) company has undertaken restructuring actions that are likely to result in annual cost savings of $100 million.
Let’s Delve Deeper
Macy’s posted adjusted earnings of $2.73 per share that comfortably beat the Zacks Consensus Estimate of $2.51 but declined 4.2% from the year-ago period. The year-over-year fall in earnings may be attributed to lower net sales. This Cincinnati, OH-based company generated net sales of $8.46 billion that decreased 2.5% year over year.
Comparable sales (comps) on an owned plus licensed basis rose 0.7%, while on an owned basis, the metric improved 0.4%. This marked the fifth straight quarter of comps growth for the company. Strategic investments across stores, technology and merchandising aided comparable sales growth.
Adjusted EBITDA declined 16.1% to $1,399 million, while adjusted EBITDA margin contracted 270 basis points to 16.5%.
Other Financial Aspects
Macy’s ended the quarter with cash and cash equivalents of $1,162 million, long-term debt of $4,708 million, and shareholders’ equity of $6,436 million.
FY19 View
Macy’s now anticipates fiscal 2019 net sales to be roughly flat with both comps on an owned plus licensed basis and comps on an owned projected to be flat to up 1%. Management now envisions adjusted earnings in the range of $3.05-$3.25 per share for fiscal 2019, down from $4.18 reported in fiscal 2018. The Zacks Consensus Estimate for the fiscal year is pegged at $3.25, which is likely to witness revision in the coming days.
Dollar Tree (DLTR - Free Report) has a long-term earnings growth rate of 13.8% and a Zacks Rank #2.
Ollie's Bargain Outlet (OLLI - Free Report) has a long-term earnings growth rate of 24.7% and carries a Zacks Rank #2.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Macy's (M) Q4 Earnings Beat, Strategic Initiatives on Track
Macy’s, Inc. (M - Free Report) delivered the seventh straight quarter of positive earnings surprise, when it reported fourth-quarter fiscal 2018 results. Management hinted that while the company registered positive comparable sales, results failed to live up to expectations. Nonetheless, the company witnessed double-digit growth in the digital business.
The company highlighted that going forward it will embark on Backstage, Vendor Direct, Store Pickup, Loyalty Program, Growth50 stores, ‘mobile first’ strategy and Destination Businesses to drive growth. The company plans to double the number of Market @ Macy’s, a store-within-a-store retail concept. This Zacks Rank #3 (Hold) company has undertaken restructuring actions that are likely to result in annual cost savings of $100 million.
Let’s Delve Deeper
Macy’s posted adjusted earnings of $2.73 per share that comfortably beat the Zacks Consensus Estimate of $2.51 but declined 4.2% from the year-ago period. The year-over-year fall in earnings may be attributed to lower net sales. This Cincinnati, OH-based company generated net sales of $8.46 billion that decreased 2.5% year over year.
Comparable sales (comps) on an owned plus licensed basis rose 0.7%, while on an owned basis, the metric improved 0.4%. This marked the fifth straight quarter of comps growth for the company. Strategic investments across stores, technology and merchandising aided comparable sales growth.
Adjusted EBITDA declined 16.1% to $1,399 million, while adjusted EBITDA margin contracted 270 basis points to 16.5%.
Other Financial Aspects
Macy’s ended the quarter with cash and cash equivalents of $1,162 million, long-term debt of $4,708 million, and shareholders’ equity of $6,436 million.
FY19 View
Macy’s now anticipates fiscal 2019 net sales to be roughly flat with both comps on an owned plus licensed basis and comps on an owned projected to be flat to up 1%. Management now envisions adjusted earnings in the range of $3.05-$3.25 per share for fiscal 2019, down from $4.18 reported in fiscal 2018. The Zacks Consensus Estimate for the fiscal year is pegged at $3.25, which is likely to witness revision in the coming days.
Check These 3 Trending Picks
Walmart Inc. (WMT - Free Report) delivered average positive earnings surprise of 5.1% in the trailing four quarters. It has a long-term earnings growth rate of 5.3% and a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Dollar Tree (DLTR - Free Report) has a long-term earnings growth rate of 13.8% and a Zacks Rank #2.
Ollie's Bargain Outlet (OLLI - Free Report) has a long-term earnings growth rate of 24.7% and carries a Zacks Rank #2.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>